SquareMind was created to help save lives and free up significant medical time with disruptive software technologies. They are proud to have the support from Calm/Storm Ventures, Entrepreneur First, id4 ventures, EIC Accelerator innovation programme, Bpifrance and great business angels.

SquareMind see themselves as the future of non-invasive healthcare, envisioning a future where autonomous robots will revolutionise healthcare systems around the world. Its approach to skin screening is not only more accessible, but also hopes to crucially unlock productivity in the demanding world of medicine.

Currently the product is not commercially available, however, SquareMind is eager to reveal Swan in 2024, the product that shall deliver upon its vision. This vision is a global one, with current proceedings taking places in the Europe and the US.

Find out even more in the interview below!